Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

Hadassah Medical Center: Bar-Shavit Rachel

Last updated June 2021 - Hadassah Medical Center

List of Publications

(1) Grisaru-Granovsky S, Kumar Nag J, Zakar L, Rudina T, Lal Gupta C, Maoz M, et al. PAR1&2 driven placenta EVT invasion act via LRP5/6 as coreceptors. FASEB J 2020;34(12):15701-15717.

(2) Nag JK, Bar-Shavit R. Transcriptional landscape of pars in epithelial malignancies. Int J Mol Sci 2018;19(11).

(3) Nag JK, Rudina T, Maoz M, Grisaru-Granovsky S, Uziely B, Bar-Shavit R. Correction to: Cancer driver G-protein coupled receptor (GPCR) induced β-catenin nuclear localization: the transcriptional junction (Cancer and Metastasis Reviews, (2018), 37, 1, (147-157), 10.1007/s10555-017-9711-z). Cancer Metastasis Rev 2018;37(1):197.

(4) Nag JK, Rudina T, Maoz M, Grisaru-Granovsky S, Uziely B, Bar-Shavit R. Cancer driver G-protein coupled receptor (GPCR) induced β-catenin nuclear localization: the transcriptional junction. Cancer Metastasis Rev 2018;37(1):147-157.

(5) Jaber M, Maoz M, Kancharla A, Agranovich D, Peretz T, Grisaru-Granovsky S, et al. Erratum to: Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer (Cellular and Molecular Life Sciences, (2014), 71, 13, (2517-2533), 10.1007/s00018-013-1498-7). Cell Mol Life Sci 2017;74(3):571-577.

(6) Nag JK, Kancharla A, Maoz M, Turm H, Agranovich D, Gupta CL, et al. Low-density lipoprotein receptor-related protein 6 is a novel coreceptor of protease-activated receptor-2 in the dynamics of cancer-associated β-catenin stabilization. Oncotarget 2017;8(24):38650-38667.

(7) Bar-Shavit R, Maoz M, Kancharla A, Nag JK, Agranovich D, Grisaru-Granovsky S, et al. G protein-coupled receptors in cancer. Int J Mol Sci 2016;17(8).

(8) Bar-Shavit R, Grisaru-Granovsky S, Uziely B. PH-domains as central modulators driving tumor growth. Cell Cycle 2016;15(5):615-616.

(9) Bar-Shavit R, Nag JK, Grisaru-Granovsky S, Uziely B. G-protein coupled receptor PAR1 is overexpressed in glioma progenitor cells. Transl Cancer Res 2016;5:S1185-S1188.

(10) Bar-Shavit R, Maoz M, Kancharla A, Jaber M, Agranovich D, Grisaru-Granovsky S, et al. Protease-activated receptors (PARs) in cancer: Novel biased signaling and targets for therapy. Methods Cell Biol 2016;132:341-358.

(11) Kancharla A, Maoz M, Jaber M, Agranovich D, Peretz T, Grisaru-Granovsky S, et al. PH motifs in PAR1&2 endow breast cancer growth. Nat Commun 2015;6.

(12) Grisaru-Granovsky S, Salah Z, Maoz M, Tevet A, Margalioth E, Samueloff A, et al. Protease-activated-receptor 1 polymorphisms correlate with risk for unexplained recurrent pregnancy loss: A pilot study querying an association beyond coagulation. European Journal of Obstetrics and Gynecology and Reproductive Biology 2015;185:13-18.

(13) Jaber M, Maoz M, Kancharla A, Agranovich D, Peretz T, Grisaru-Granovsky S, et al. Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer. Cell Mol Life Sci 2014;71(13):2517-2533.

(14) Grisaru-Granovsky S, Maoz M, Turm H, Bar-Shavit R. Emerging tasks of PAR1 and PAR2 in the placenta trophoblast anchoring to the uterus deciduas. The Placenta: Development, Function and Diseases; 2013. p. 31-42.

(15) Uziely B, Maoz M, Salah Z, Jaber M, Turm H, Grisaru-Granovsky S, et al. Emerging tasks of thrombin and its receptors in epithelial tumor development. Thrombin: Function and Pathophysiology; 2012. p. 199-213.

(16) Salah Z, Uziely B, Jaber M, Maoz M, Cohen I, Hamburger T, et al. Regulation of human protease-activated receptor 1 (hPar1) gene expression in breast cancer by estrogen. FASEB J 2012;26(5):2031-2042.

(17) Bar-Shavit R, Turm H, Salah Z, Maoz M, Cohen I, Weiss E, et al. PAR1 plays a role in epithelial malignancies: Transcriptional regulation and novel signaling pathway. IUBMB Life 2011;63(6):397-402.

(18) Turm H, Grisaru-Granvosky S, Maoz M, Offermanns S, Bar-Shavit R. DVL as a scaffold protein capturing classical GPCRs. Commun Integr Biol 2010;3(6):495-498.

(19) Cohen I, Maoz M, Turm H, Grisaru-Granovsky S, Maly B, Uziely B, et al. Etk/Bmx regulates proteinase-activated-receptor1 (PAR1) in breast cancer invasion: Signaling partners, hierarchy and physiological significance. PLoS ONE 2010;5(6).

(20) Turm H, Maoz M, Katz V, Yin Y-, Offermanns S, Bar-Shavit R. Protease-activated receptor-1 (PAR1) acts via a novel Gα 13-dishevelled axis to stabilize β-catenin levels. J Biol Chem 2010;285(20):15137-15148.

(21) Grisaru-Granovsky S, Maoz M, Barzilay O, Yin Y-, Prus D, Bar-Shavit R. Protease Activated Receptor-1, PAR1, promotes placenta trophoblast invasion and β-catenin stabilization. J Cell Physiol 2009;218(3):512-521.

(22) Salah Z, Grisaru-Granovsky S, Maoz M, Uziely B, Cohen I, Turm H, et al. The role of thrombin and its receptors in epithelial malignancies: Lessons from a transgenic mouse model and transcriptional regulation. Thrombin: Physiology and Disease; 2009. p. 173-188.

(23) Salah Z, Haupt S, Maoz M, Baraz L, Rotter V, Peretz T, et al. p53 controls hPar1 function and expression. Oncogene 2008;27(54):6866-6874.

(24) Shavit E, Beilin O, Korczyn AD, Sylantiev C, Aronovich R, Drory VE, et al. Thrombin receptor PAR-1 on myelin at the node of Ranvier: A new anatomy and physiology of conduction block. Brain 2008;131(4):1113-1122.

(25) Grisaru-Granovsky S, Tevet A, Bar-Shavit R, Salah Z, Elstein D, Samueloff A, et al. Association study of protease activated receptor 1 gene polymorphisms and adverse pregnancy outcomes: Results of a pilot study in Israel. Am J Med Genet Part A 2007;143(21):2557-2563.

(26) Salah Z, Maoz M, Pizov G, Bar-Shavit R. Transcriptional regulation of human protease-activated receptor 1: A role for the early growth response-1 protein in prostate cancer. Cancer Res 2007;67(20):9835-9843.

(27) Salah Z, Maoz M, Pokroy E, Lotem M, Bar-Shavit R, Uziely B. Protease-activated receptor-1 (hPar1), a survival factor eliciting tumor progression. Mol Cancer Res 2007;5(3):229-240.

(28) Granovsky-Grisaru S, Zaidoun S, Grisaru D, Yekel Y, Prus D, Beller U, et al. The pattern of Protease Activated Receptor 1 (PAR1) expression in endometrial carcinoma. Gynecol Oncol 2006;103(3):802-806.

(29) Yin Y-, Katz V, Salah Z, Maoz M, Cohen I, Uziely B, et al. Mammary gland tissue targeted overexpression of human protease-activated receptor 1 reveals a novel link to β-catenin stabilization. Cancer Res 2006;66(10):5224-5233.

(30) Cohen I, Pappo O, Elkin M, San T, Bar-Shavit R, Hazan R, et al. Heparanase promotes growth, angiogenesis and survival of primary breast tumors. Int J Cancer 2006;118(7):1609-1617.

(31) Grisaru-Granovsky S, Salah Z, Maoz M, Pruss D, Beller U, Bar-Shavit R. Differential expression of Protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples. Int J Cancer 2005;113(3):372-378.

(32) Salah Z, Maoz M, Cohen I, Pizov G, Pode D, Runge MS, et al. Identification of a novel functional androgen response element within hPar1 promoter: Implications to prostate cancer progression. FASEB J 2005;19(1):62-72.

(33) Yin Y-, Salah Z, Grisaru-Granovsky S, Cohen I, Even-Ram SC, Maoz M, et al. Human protease-activated receptor 1 expression in malignant epithelia: A role in invasiveness. Arterioscler Thromb Vasc Biol 2003;23(6):940-944.

(34) Even-Ram SC, Grisaru-Granovsky S, Pruss D, Maoz M, Salah Z, Yong-Jun Y, et al. The pattern of expression of protease-activated receptors (PARs) during early trophoblast development. J Pathol 2003;200(1):47-52.

(35) Yin Y-, Salah Z, Maoz M, Ram SCE, Ochayon S, Neufeld G, et al. Oncogenic transformation induces tumor angiogenesis: A role for PAR1 activation. FASEB J 2003;17(2):163-174.

(36) Nassar T, Akkawi S, Bar-Shavit R, Haj-Yehia A, Bdeir K, Al-Mehdi A-, et al. Human α-defensin regulates smooth muscle cell contraction: A role for low-density lipoprotein receptor-related protein/α2-macroglobulin receptor. Blood 2002;100(12):4026-4032.

(37) Bar-Shavit R, Maoz M, Yongjun Y, Groysman M, Dekel I, Katzav S. Signalling pathways induced by protease-activated receptors and integrins in T cells. Immunology 2002;105(1):35-46.

(38) Schiffenbauer YS, Meir G, Maoz M, Even-Ram SC, Bar-Shavit R, Neeman M. Gonadotropin stimulation of MLS human epithelial ovarian carcinoma cells augments cell adhesion mediated by CD44 and by αv-integrin. Gynecol Oncol 2002;84(2):296-302.

(39) Even-Ram SC, Maoz M, Pokroy E, Reich R, Katz B-, Gutwein P, et al. Tumor Cell Invasion Is Promoted by Activation of Protease Activated Receptor-1 in Cooperation with the αvβ5 Integrin. J Biol Chem 2001;276(14):10952-10962.

(40) Landau E, Tirosh R, Pinson A, Banai S, Even-Ram S, Maoz M, et al. Protection of thrombin receptor expression under hypoxia. J Biol Chem 2000;275(4):2281-2287.

(41) Even-Ram S, Uziely B, Cohen P, Grisaru-Granovsky S, Maoz M, Ginzburg Y, et al. Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med 1998;4(8):909-914.

(42) Bar-Shavit R, Maoz M, Ginzburg Y, Vlodavsky I. Specific involvement of glypican in thrombin adhesive properties. J Cell Biochem 1996;61(2):278-291.

(43) Bar-Shavit R, Maoz M, Ginzburg Y, Vlodavsky I. Erratum: Specific involvement of Glypican in thrombin adhesive properties (Journal of Cell Biochemistry (1996) 61 (278-291)). J Cell Biochem 1996;62(1):144.

(44) Bar-Shavit R, Ginzburg Y, Maoz M, Vlodavsky I, Peretz T. The involvement of thrombin RGD in metastasis: Characterization of a cryptic adhesive site. Isr J Med Sci 1995;31(2-3):86-94.

(45) Vlodavsky I, Miao H-, Atzmon R, Levi E, Zimmermann J, Bar-Shavit R, et al. Control of cell proliferation by heparan sulfate and heparin-binding growth factors. Thromb Haemost 1995;74(1):534-540.

(46) Bitan M, Mohsen M, Levi E, Wygoda MR, Miao H-, Lider O, et al. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin. Isr J Med Sci 1995;31(2-3):106-118.

(47) Herbert J-, Dupuy E, Laplace M-, Zini J-, Bar Shavit R, Tobelem G. Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway. Biochem J 1994;303(1):227-231.

(48) Benezra M, Ben-Sasson SA, Regan J, Chang M, Bar-Shavit R, Vlodavsky I. Antiproliferative activity to vascular smooth muscle cells and receptor binding of heparin-mimicking polyaromatic anionic compounds. Arterioscler Thromb Vasc Biol 1994;14(12):1992-1999.

(49) Bar-Shavit R, Eskohjido Y, Fenton II JW, Esko JD, Vlodavsky I. Thrombin adhesive properties: Induction by plasmin and heparan sulfate. J Cell Biol 1993;123(5):1279-1287.

(50) Benezra M, Vlodavsky I, Bar-Shavit R. Prothrombin conversion to thrombin by plasminogen activator residing in the subendothelial extracellular matrix. Semin Thromb Hemost 1993;19(4):405-411.

(51) Vettel U, Brunner G, Bar‐Shavit R, Vlodavsky I, Kramer MD. Charge‐dependent binding of granzyme A (MTSP‐1) to basement membranes. Eur J Immunol 1993;23(1):279-282.

(52) Benezra M, Vlodavsky I, Ishai-Michaeli R, Neufeld G, Bar-Shavit R. Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix. Blood 1993;81(12):3324-3331.

(53) Benezra M, Vlodavsky I, Bar-Shavit R. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase. Exp Cell Res 1992;201(1):208-215.

(54) Bar-Shavit R, Benezra M, Sabbah V, Bode W, Vlodavsky I. Thrombin as a multifunctional protein: induction of cell adhesion and proliferation. Am J Respir Cell Mol Biol 1992;6(2):123-130.

(55) Vlodavsky I, Ishai-Michaeli R, Mohsen M, Bar-Shavit R, Catane R, Ekre H-T, et al. Modulation of neovascularization and metastasis by species of heparin. Adv Exp Med Biol 1992;313:317-327.

(56) Bar-Shavit R, Sabbah V, Grazia Lampugnani MG, Marchisio PC, Fenton II JW, Vlodavsky I, et al. An Arg-Gly-Asp sequence within thrombin promotes endothelial cell adhesion. J Cell Biol 1991;112(2):335-344.

(57) Vlodavsky I, Bar-Shavit R, Ishar-Michael R, Bashkin P, Fuks Z. Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem Sci 1991;16(C):268-271.

(58) Vettel U, Bar‐Shavit R, Simon MM, Brunner G, Vlodavsky I, Kramer MD. Coordinate secretion and functional synergism of T cell‐associated serine proteinase‐1 (MTSP‐1) and endoglycosidase(s) of activated T cells. Eur J Immunol 1991;21(9):2247-2251.

(59) VLOAVSKY I, BASHKIN P, ISHAI‐MICHAELI R, CHAJEK‐SHAUL T, BAR‐SHAVIT R, HAIMOVITZ‐FRIEDMAN A, et al. Sequestration and Release of Basic Fibroblast Growth Factor. Ann New York Acad Sci 1991;638(1):207-220.

(60) Vlodavsky I, Ishai‐Michaeli R, Bashkin P, Levi E, Korner G, Bar‐Shavit R, et al. Extracellular matrix‐resident basic fibroblast growth factor: Implication for the control of angiogenesis. J Cell Biochem 1991;45(2):167-176.

(61) Vlodavsky I, Korner G, Ishai-Michaeli R, Bashkin P, Bar-Shavit R, Fuks Z. Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer Metast Rev 1990;9(3):203-226.

(62) Chajek-Shaul T, Friedman G, Bengtsson-Olivecrona G, Vlodavsky I, Bar-Shavit R. Interaction of lipoprotein lipase with subendothelial extracellular matrix. Biochim Biophys Acta Lipids Lipid Metab 1990;1042(2):168-175.

(63) Bar-Shavit R, Benezra M, Eldor A, Hy-Am E, Fenton II JW, Wilner GD, et al. Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: Nonenzymatic mode of action. Mol Biol Cell 1990;1(6):453-463.

(64) Bar-Shavit R, Eldor A, Vlodavsky I. Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties. J Clin Invest 1989;84(4):1096-1104.

(65) Spira O, Atzmon R, Rahamim E, Bar-Shavit R, Gross J, Gordon A, et al. Striated muscle fibers differentiate in primary cultures of adult anterior pituitary cells. Endocrinology 1988;122(6):3002-3004.

(66) Bar‐Shavit R, Hruska KA, Kahn AJ, Wilner GD. Thrombin chemotactic stimulation of HL‐60 cells: Studies on thrombin responsiveness as a function of differentiation. J Cell Physiol 1987;131(2):255-261.

(67) Bar-Shavit R, Wilner GD. Biologic activities of nonenzymatic thrombin: Elucidation of a macrophage interactive domain. Semin Thromb Hemost 1986;12(3):244-249.

(68) Bar-Shavit R, Wilner GD. Mediation of cellular events by thrombin. Int Rev Exp Pathol 1986;Vol. 29:213-241.

(69) Bar-Shavit R, Kahn AJ, Mann KG, Wilner GD. Identification of a thrombin sequence with growth factor activity on macrophages. Proc Natl Acad Sci U S A 1986;83(4):976-980.

(70) Bar-Shavit R, Kahn AJ, Mann KG, Wilner GD. Growth-promoting effects of esterolytically inactive thrombin on macrophages. J Cell Biochem 1986;32(4):261-272.

(71) BAR‐SHAVIT R, HRUSKA KA, KAHN AJ, WILNER GD. Hormone‐Like Activity of Human Thrombin. Ann New York Acad Sci 1986;485(1):335-348.

(72) Shainberg A, Brik H, Bar Shavit R, Sampson SR. Inhibition of acetylcholine receptor synthesis by thyroid hormones. J Endocrinol 1984;101(2):141-147.

(73) Bar-Shavit R, Kahn A, Mudd MS, Wilner GD, Mann KG, Fenton JW. Localization of a Chemotactic Domain in Human Thrombin. Biochemistry 1984;23(3):397-400.

(74) Bar Shavit R, Kahn A, Fenton II JW, Wilner GD. Receptor-mediated chemotactic response of a macrophage cell line (J774) to thrombin. Lab Invest 1983;49(6):702-707.

(75) Bar-Shavit R, Kahn A, Fenton II JW, Wilner GD. Chemotactic response of monocytes to thrombin. J Cell Biol 1983;96(1):282-285.

(76) Bar-Shavit R, Kahn A, Wilner GD, Fenton II JW. Monocyte chemotaxis: Stimulation by specific exosite region in thrombin. Science 1983;220(4598):728-731.

(77) Bar Shavit R, Kahn A, Fenton II JW, Wilner GD. Chemotactic response of monocytes to thrombin. Clin Res 1982;30(4).

(78) DePamphilis ML, Anderson S, Bar-Shavit R, Collins E, Edenberg H, Herman T, et al. Replication and structure of simian virus 40 chromosomes. COLD SPRING HARBOR SYMP QUANT BIOL 1979;43(2):679-692.

(79) Kaufmann G, Bar-Shavit R, Depamphilis ML. Okazaki pieces grow opposite to the replication fork direction during simian virus 40 DNA replication. Nucleic Acids Res 1978;5(7):2535-2546.

(80) Bar-Shavit R, Laub O, Aloni Y. The Frequencies of Transcription from the E- and L-Strands of Polyoma DNA. J Gen Virol 1978;39(2):357-360.